Shusuke Akamatsu

Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma

T. Soga, N. Tanuma, Keisuke Yaku, 2023, Nature communications.

Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

T. Ishikawa, Y. Matsukawa, Yasuyuki Mizutani, 2024, British Journal of Cancer.

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

Takeshi Onoue, N. Nishio, Mariko Sugiyama, 2024, Cancer immunology, immunotherapy : CII.

Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate

T. Tsuzuki, Y. Matsukawa, S. Ishida, 2023, International journal of urology : official journal of the Japanese Urological Association.

Treatment escalation and de-escalation of de-novo metastatic castration-sensitive prostate cancer

Y. Matsukawa, S. Ishida, T. Sano, 2024, Nagoya journal of medical science.